Home

Download

Statistics

Examples

Help

Contact

Gene: ENSG00000065923

Summary for SLC9A7

Gene summary

Gene information	Ensembl ID	ENSG00000065923
	Gene symbol	SLC9A7
	Gene name	solute carrier family 9 member A7
	HGNC	17123
	Entrez ID	84679
	Gene type	protein_coding
	Synonyms	SLC9A7\|NHE7
	UniProtAcc	Q96T83

Drugs associated with this gene(DrugBank).

Gene ID

Gene Symbol

Drug ID

Drug Name

Drug Type

Cancer therapeutic drugs associated with this gene(NCI).

Gene ID

Gene Name

Drug ID

Drug Name

Drug Type

Cancer

Top

Structure and expression level for SLC9A7

AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.
∗For more information on exon skipping events please check the ExonskipDB database.
∗For more information on exon skipping events please check the CAeditome database.

Landscape of gene expressions across multiple cancer types.

Differentially expressed gene analysis between tumor male and tumor female samples.

Coding Name

Base Mean

log2FoldChange

lfcSE

Stat

P value

P.adjust Value

Cancer Type

Differentially expressed gene analysis between tumor male and normal male samples.

Coding Name	Base Mean	log2FoldChange	lfcSE	Stat	P value	P.adjust Value	Cancer Type
SLC9A7	1.31e+03	1.62e+00	3.63e-01	4.45e+00	8.64e-06	5.19e-05	BLCA

Differentially expressed gene analysis between tumor female and normal female samples.

Coding Name	Base Mean	log2FoldChange	lfcSE	Stat	P value	P.adjust Value	Cancer Type
SLC9A7	2.40e+03	1.37e+00	1.96e-01	7.01e+00	2.46e-12	2.15e-11	KICH
SLC9A7	3.60e+02	1.09e+00	4.22e-01	2.58e+00	9.94e-03	2.46e-02	READ

Top

Sex-biased somatic mutation for SLC9A7

∗For more information on exon skipping events please check the ExonskipDB database.

Gene ID

Cancer Type

Hugo Symbol

Male

Female

pval

ci.up

ci.low

adjPval

Top

DNA methylation with beta values for SLC9A7

Landscape of DNA methylation across multiple cancer types.

Differentially expressed CpG sites between male tumor and female tumor patients.

Cancer Type	CpG Site	Position	CpG Island	Position to Gene	ave1	ave2	wilcoxon.w	wilcoxon.p	padj	dBeta
BRCA	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	3.10e-01	5.10e-02	5.16e+00	2.48e-07	1.16e-05	2.59e-01
BRCA	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.79e-01	1.59e-02	5.16e+00	2.43e-07	1.16e-05	4.63e-01
BRCA	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	5.43e-01	2.06e-02	5.16e+00	2.43e-07	1.16e-05	5.22e-01
BRCA	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	4.37e-01	1.97e-02	5.16e+00	2.43e-07	1.16e-05	4.17e-01
BRCA	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.38e-01	3.53e-02	5.16e+00	2.43e-07	1.16e-05	4.02e-01
BRCA	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	4.42e-01	6.84e-02	5.16e+00	2.43e-07	1.16e-05	3.74e-01
BRCA	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	4.77e-01	5.61e-02	5.16e+00	2.43e-07	1.16e-05	4.21e-01
BRCA	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	3.78e-01	1.78e-01	4.19e+00	2.82e-05	5.88e-04	2.00e-01
LGG	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	2.92e-01	7.14e-02	1.94e+01	3.48e-84	9.52e-83	2.20e-01
LGG	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.73e-01	1.65e-02	1.98e+01	3.52e-87	2.64e-85	4.56e-01
LGG	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	5.15e-01	1.95e-02	1.98e+01	3.52e-87	2.64e-85	4.95e-01
LGG	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	3.62e-01	2.06e-02	1.97e+01	1.07e-86	5.00e-85	3.42e-01
LGG	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.34e-01	3.92e-02	1.98e+01	4.84e-87	2.77e-85	3.95e-01
LGG	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	4.12e-01	7.09e-02	1.98e+01	4.17e-87	2.65e-85	3.41e-01
LGG	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	4.71e-01	6.67e-02	1.98e+01	4.12e-87	2.64e-85	4.05e-01
LGG	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	4.62e-01	2.93e-01	9.70e+00	3.01e-22	2.14e-21	1.69e-01
THCA	cg06128881	chrX:46757407	CGI:chrX:46758578-46759534	promoter,gene body	6.98e-01	5.38e-01	7.92e+00	2.45e-15	1.48e-14	1.60e-01
HNSC	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	5.35e-01	3.94e-01	8.14e+00	3.86e-16	5.99e-15	1.41e-01
LUSC	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	3.32e-01	8.58e-02	1.44e+01	4.84e-47	1.57e-45	2.46e-01
LUSC	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.82e-01	2.02e-02	1.44e+01	3.09e-47	1.27e-45	4.62e-01
LUSC	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	5.30e-01	2.37e-02	1.45e+01	2.50e-47	1.26e-45	5.06e-01
LUSC	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	4.39e-01	2.38e-02	1.45e+01	1.93e-47	1.26e-45	4.15e-01
LUSC	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	4.59e-01	3.16e-01	8.56e+00	1.12e-17	1.11e-16	1.43e-01
LUSC	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.11e-01	4.35e-02	1.44e+01	2.54e-47	1.26e-45	3.68e-01
LUSC	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	4.30e-01	7.72e-02	1.45e+01	2.17e-47	1.26e-45	3.53e-01
LUSC	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	4.61e-01	6.18e-02	1.45e+01	2.35e-47	1.26e-45	4.00e-01
LUSC	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	3.58e-01	1.47e-01	1.32e+01	1.38e-39	2.21e-38	2.11e-01
SKCM	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	2.86e-01	6.85e-02	1.79e+01	1.09e-71	3.53e-70	2.17e-01
SKCM	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.30e-01	1.79e-02	1.82e+01	4.14e-74	3.59e-72	4.12e-01
SKCM	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	4.78e-01	2.33e-02	1.81e+01	1.93e-73	9.81e-72	4.54e-01
SKCM	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	3.37e-01	1.79e-02	1.82e+01	3.69e-74	3.59e-72	3.19e-01
SKCM	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.78e-01	3.22e-01	6.32e+00	2.59e-10	1.55e-09	1.56e-01
SKCM	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	3.65e-01	7.40e-02	1.81e+01	3.41e-73	1.56e-71	2.91e-01
SKCM	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	3.98e-01	6.15e-02	1.82e+01	3.56e-74	3.59e-72	3.37e-01
SKCM	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	3.13e-01	1.53e-01	1.35e+01	2.28e-41	2.85e-40	1.60e-01
BLCA	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	5.06e-01	3.90e-01	6.01e+00	1.88e-09	1.69e-08	1.16e-01
STAD	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	3.30e-01	6.77e-02	1.50e+01	4.00e-51	1.58e-49	2.62e-01
STAD	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.86e-01	1.73e-02	1.52e+01	7.06e-52	4.96e-50	4.69e-01
STAD	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	5.53e-01	2.09e-02	1.52e+01	6.93e-52	4.96e-50	5.32e-01
STAD	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	4.41e-01	2.09e-02	1.51e+01	8.89e-52	5.09e-50	4.20e-01
STAD	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	5.28e-01	3.80e-01	7.78e+00	7.43e-15	6.87e-14	1.48e-01
STAD	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.34e-01	4.46e-02	1.51e+01	1.31e-51	6.43e-50	3.90e-01
STAD	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	4.26e-01	7.24e-02	1.51e+01	1.12e-51	5.79e-50	3.53e-01
STAD	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	4.63e-01	5.78e-02	1.52e+01	7.06e-52	4.96e-50	4.05e-01
STAD	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	3.67e-01	1.55e-01	1.24e+01	4.16e-35	7.30e-34	2.12e-01
LIHC	cg06128881	chrX:46757407	CGI:chrX:46758578-46759534	promoter,gene body	8.29e-01	9.36e-01	-7.78e+00	7.14e-15	1.58e-13	-1.06e-01
SARC	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	2.66e-01	6.60e-02	1.29e+01	3.05e-38	1.29e-36	2.00e-01
SARC	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.14e-01	1.68e-02	1.39e+01	1.13e-43	6.43e-41	3.97e-01
SARC	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	4.59e-01	2.05e-02	1.39e+01	3.80e-44	6.21e-41	4.39e-01
SARC	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	3.10e-01	1.95e-02	1.37e+01	5.38e-43	8.09e-41	2.91e-01
SARC	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.03e-01	6.14e-02	1.35e+01	1.22e-41	8.76e-40	3.41e-01
SARC	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	3.40e-01	8.08e-02	1.34e+01	3.94e-41	2.48e-39	2.59e-01
SARC	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	3.96e-01	6.54e-02	1.38e+01	1.55e-43	6.60e-41	3.31e-01
SARC	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	2.76e-01	9.59e-02	1.14e+01	2.96e-30	7.67e-29	1.81e-01
PCPG	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	1.87e-01	6.97e-02	1.13e+01	2.19e-29	3.96e-28	1.18e-01
PCPG	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	3.45e-01	1.61e-02	1.15e+01	1.61e-30	4.12e-29	3.29e-01
PCPG	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	3.78e-01	2.12e-02	1.16e+01	4.51e-31	1.94e-29	3.57e-01
PCPG	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	2.30e-01	1.87e-02	1.16e+01	5.86e-31	2.11e-29	2.11e-01
PCPG	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	4.13e-01	2.70e-01	6.64e+00	3.04e-11	1.77e-10	1.43e-01
PCPG	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.28e-01	4.78e-02	1.14e+01	2.62e-30	6.03e-29	3.80e-01
PCPG	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	2.83e-01	8.36e-02	1.16e+01	7.37e-31	2.43e-29	2.00e-01
PCPG	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	3.74e-01	6.31e-02	1.15e+01	1.67e-30	4.22e-29	3.11e-01
PCPG	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	2.86e-01	1.57e-01	7.33e+00	2.35e-13	1.50e-12	1.29e-01
PAAD	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	3.06e-01	6.34e-02	1.15e+01	2.10e-30	1.01e-28	2.43e-01
PAAD	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.73e-01	1.62e-02	1.15e+01	2.03e-30	1.01e-28	4.56e-01
PAAD	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	5.28e-01	2.11e-02	1.15e+01	2.03e-30	1.01e-28	5.06e-01
PAAD	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	4.14e-01	2.06e-02	1.15e+01	2.03e-30	1.01e-28	3.93e-01
PAAD	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	5.31e-01	3.96e-01	6.94e+00	3.79e-12	3.50e-11	1.35e-01
PAAD	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.41e-01	4.58e-02	1.15e+01	2.10e-30	1.01e-28	3.95e-01
PAAD	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	3.86e-01	7.76e-02	1.15e+01	2.24e-30	1.01e-28	3.09e-01
PAAD	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	4.52e-01	6.18e-02	1.15e+01	2.03e-30	1.01e-28	3.90e-01
PAAD	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	3.45e-01	1.06e-01	1.12e+01	2.94e-29	8.21e-28	2.39e-01
READ	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	3.17e-01	7.00e-02	8.46e+00	2.75e-17	4.73e-16	2.47e-01
READ	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.36e-01	1.38e-02	8.49e+00	2.15e-17	4.34e-16	4.22e-01
READ	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	5.24e-01	1.70e-02	8.49e+00	2.15e-17	4.34e-16	5.07e-01
READ	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	4.63e-01	1.69e-02	8.49e+00	2.15e-17	4.34e-16	4.46e-01
READ	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	3.80e-01	4.30e-02	8.49e+00	2.15e-17	4.34e-16	3.37e-01
READ	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	4.70e-01	7.32e-02	8.49e+00	2.15e-17	4.34e-16	3.97e-01
READ	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	4.72e-01	5.93e-02	8.49e+00	2.15e-17	4.34e-16	4.12e-01
READ	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	3.91e-01	1.52e-01	7.00e+00	2.57e-12	2.46e-11	2.39e-01
GBM	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	3.47e-01	6.43e-02	6.75e+00	1.48e-11	2.64e-10	2.83e-01
GBM	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	5.22e-01	1.61e-02	6.75e+00	1.48e-11	2.64e-10	5.06e-01
GBM	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	5.84e-01	1.96e-02	6.75e+00	1.48e-11	2.64e-10	5.64e-01
GBM	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	4.76e-01	1.82e-02	6.75e+00	1.48e-11	2.64e-10	4.58e-01
GBM	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.57e-01	4.38e-02	6.75e+00	1.48e-11	2.64e-10	4.13e-01
GBM	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	5.14e-01	7.24e-02	6.75e+00	1.48e-11	2.64e-10	4.41e-01
GBM	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	5.09e-01	6.76e-02	6.75e+00	1.48e-11	2.64e-10	4.42e-01
GBM	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	4.83e-01	2.30e-01	4.32e+00	1.56e-05	8.95e-05	2.53e-01
ESCA	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	3.28e-01	6.39e-02	7.61e+00	2.78e-14	6.84e-13	2.65e-01
ESCA	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.80e-01	1.90e-02	7.63e+00	2.39e-14	6.84e-13	4.61e-01
ESCA	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	5.42e-01	2.43e-02	7.60e+00	2.88e-14	6.84e-13	5.18e-01
ESCA	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	4.49e-01	2.27e-02	7.57e+00	3.73e-14	6.84e-13	4.26e-01
ESCA	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	4.97e-01	3.56e-01	4.02e+00	5.73e-05	3.19e-04	1.40e-01
ESCA	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.23e-01	4.45e-02	7.58e+00	3.34e-14	6.84e-13	3.78e-01
ESCA	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	4.48e-01	7.68e-02	7.60e+00	2.88e-14	6.84e-13	3.72e-01
ESCA	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	4.78e-01	5.93e-02	7.58e+00	3.47e-14	6.84e-13	4.18e-01
ESCA	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	3.70e-01	1.39e-01	6.83e+00	8.43e-12	8.58e-11	2.31e-01
LAML	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	3.88e-01	8.37e-02	1.01e+01	4.03e-24	2.70e-22	3.04e-01
LAML	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	5.15e-01	2.57e-02	1.03e+01	7.62e-25	2.70e-22	4.89e-01
LAML	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	5.73e-01	3.49e-02	9.94e+00	2.83e-23	4.92e-22	5.38e-01
LAML	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	4.30e-01	2.88e-02	1.02e+01	1.50e-24	2.70e-22	4.01e-01
LAML	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	5.36e-01	2.74e-01	6.66e+00	2.73e-11	1.30e-10	2.61e-01
LAML	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.64e-01	3.98e-02	9.99e+00	1.65e-23	3.67e-22	4.24e-01
LAML	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	4.49e-01	7.62e-02	1.00e+01	1.52e-23	3.58e-22	3.73e-01
LAML	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	4.85e-01	4.76e-02	1.00e+01	1.30e-23	3.33e-22	4.38e-01
LAML	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	4.14e-01	1.29e-01	9.31e+00	1.26e-20	1.09e-19	2.85e-01
THYM	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	2.87e-01	9.05e-02	9.40e+00	5.48e-21	1.00e-19	1.96e-01
THYM	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.69e-01	1.43e-02	9.40e+00	5.48e-21	1.00e-19	4.55e-01
THYM	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	5.10e-01	1.81e-02	9.40e+00	5.48e-21	1.00e-19	4.92e-01
THYM	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	3.55e-01	2.25e-02	9.40e+00	5.48e-21	1.00e-19	3.33e-01
THYM	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	5.50e-01	3.99e-01	4.75e+00	2.03e-06	7.06e-06	1.51e-01
THYM	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.13e-01	4.11e-02	9.40e+00	5.48e-21	1.00e-19	3.71e-01
THYM	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	3.75e-01	7.34e-02	9.40e+00	5.48e-21	1.00e-19	3.02e-01
THYM	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	4.57e-01	5.94e-02	9.40e+00	5.48e-21	1.00e-19	3.98e-01
THYM	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	3.58e-01	1.35e-01	8.34e+00	7.37e-17	5.45e-16	2.23e-01
MESO	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	2.71e-01	7.03e-02	6.06e+00	1.36e-09	2.54e-08	2.00e-01
MESO	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.33e-01	1.58e-02	6.06e+00	1.36e-09	2.54e-08	4.17e-01
MESO	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	4.82e-01	2.08e-02	6.06e+00	1.36e-09	2.54e-08	4.62e-01
MESO	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	3.10e-01	2.19e-02	6.06e+00	1.36e-09	2.54e-08	2.89e-01
MESO	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	3.48e-01	4.46e-02	6.05e+00	1.46e-09	2.54e-08	3.03e-01
MESO	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	3.44e-01	7.99e-02	6.06e+00	1.36e-09	2.54e-08	2.64e-01
MESO	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	3.77e-01	5.54e-02	6.06e+00	1.36e-09	2.54e-08	3.22e-01
MESO	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	3.14e-01	9.09e-02	5.68e+00	1.31e-08	1.41e-07	2.23e-01
UVM	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	2.40e-01	8.60e-02	6.51e+00	7.39e-11	5.93e-10	1.54e-01
UVM	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	3.51e-01	1.55e-02	7.64e+00	2.21e-14	9.97e-13	3.35e-01
UVM	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	3.28e-01	1.85e-02	7.64e+00	2.21e-14	9.97e-13	3.09e-01
UVM	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	2.44e-01	2.04e-02	7.56e+00	4.03e-14	1.06e-12	2.24e-01
UVM	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.26e-01	1.91e-01	5.47e+00	4.63e-08	2.61e-07	2.35e-01
UVM	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	2.70e-01	7.25e-02	7.15e+00	8.51e-13	9.51e-12	1.98e-01
UVM	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	3.25e-01	6.53e-02	7.53e+00	5.04e-14	1.15e-12	2.60e-01
UVM	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	2.49e-01	1.40e-01	4.61e+00	3.99e-06	1.71e-05	1.09e-01
ACC	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.30e-01	1.69e-02	7.47e+00	8.02e-14	2.68e-12	4.13e-01
ACC	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	3.44e-01	7.25e-02	7.47e+00	8.02e-14	2.68e-12	2.71e-01
ACC	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	3.87e-01	5.77e-02	7.47e+00	8.02e-14	2.68e-12	3.29e-01
ACC	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	2.68e-01	8.09e-02	7.45e+00	9.34e-14	2.69e-12	1.88e-01
ACC	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	4.67e-01	1.88e-02	7.47e+00	8.02e-14	2.68e-12	4.49e-01
ACC	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.31e-01	3.49e-02	7.46e+00	8.66e-14	2.68e-12	3.96e-01
ACC	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	3.14e-01	1.98e-02	7.47e+00	8.02e-14	2.68e-12	2.94e-01
KICH	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	2.24e-01	8.91e-02	6.67e+00	2.58e-11	1.88e-09	1.35e-01
KICH	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	3.41e-01	2.15e-02	6.71e+00	1.96e-11	1.88e-09	3.20e-01
KICH	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	3.83e-01	2.67e-02	6.60e+00	4.07e-11	1.88e-09	3.56e-01
KICH	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	2.03e-01	2.18e-02	6.67e+00	2.58e-11	1.88e-09	1.82e-01
KICH	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	4.80e-01	3.70e-01	2.30e+00	2.13e-02	3.81e-02	1.10e-01
KICH	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	2.85e-01	5.28e-02	6.51e+00	7.62e-11	1.94e-09	2.32e-01
KICH	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	2.15e-01	7.97e-02	6.39e+00	1.69e-10	3.26e-09	1.36e-01
KICH	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	2.90e-01	7.93e-02	6.52e+00	6.97e-11	1.88e-09	2.11e-01
KICH	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	2.26e-01	7.17e-02	5.84e+00	5.27e-09	6.39e-08	1.54e-01
DLBC	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	2.88e-01	5.70e-02	5.90e+00	3.70e-09	5.58e-08	2.31e-01
DLBC	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.30e-01	1.48e-02	5.92e+00	3.26e-09	5.31e-08	4.16e-01
DLBC	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	4.88e-01	1.91e-02	5.92e+00	3.26e-09	5.31e-08	4.69e-01
DLBC	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	3.74e-01	1.83e-02	5.92e+00	3.26e-09	5.31e-08	3.56e-01
DLBC	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	3.53e-01	4.53e-02	5.92e+00	3.26e-09	5.31e-08	3.08e-01
DLBC	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	3.86e-01	7.36e-02	5.92e+00	3.26e-09	5.31e-08	3.12e-01
DLBC	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	4.26e-01	5.48e-02	5.92e+00	3.26e-09	5.31e-08	3.71e-01
DLBC	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	2.88e-01	1.23e-01	4.39e+00	1.15e-05	8.08e-05	1.65e-01
CHOL	cg17404000	chrX:46759195	CGI:chrX:46758578-46759534	promoter	3.32e-01	3.52e-02	5.09e+00	3.51e-07	4.92e-06	2.97e-01
CHOL	cg04027312	chrX:46759197	CGI:chrX:46758578-46759534	promoter	4.90e-01	1.90e-02	5.09e+00	3.51e-07	4.92e-06	4.71e-01
CHOL	cg17639056	chrX:46759204	CGI:chrX:46758578-46759534	promoter	5.72e-01	2.61e-02	5.09e+00	3.51e-07	4.92e-06	5.46e-01
CHOL	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	4.18e-01	1.77e-02	5.09e+00	3.51e-07	4.92e-06	4.00e-01
CHOL	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	5.05e-01	3.62e-01	2.32e+00	2.01e-02	3.30e-02	1.43e-01
CHOL	cg18799866	chrX:46758729	CGI:chrX:46758578-46759534	promoter,exon,CDS,gene body	4.31e-01	4.09e-02	5.09e+00	3.51e-07	4.92e-06	3.90e-01
CHOL	cg12373280	chrX:46759425	CGI:chrX:46758578-46759534	promoter	4.45e-01	7.17e-02	5.09e+00	3.51e-07	4.92e-06	3.73e-01
CHOL	cg14841098	chrX:46759533	CGI:chrX:46758578-46759534	promoter	4.93e-01	5.05e-02	5.09e+00	3.51e-07	4.92e-06	4.43e-01
CHOL	cg26068514	chrX:46759800	CGI:chrX:46758578-46759534	promoter	3.95e-01	1.65e-01	4.17e+00	3.04e-05	1.78e-04	2.31e-01

Differentially expressed CpG sites between male tumor and male normal patients.

Cancer Type	CpG Site	Position	CpG Island	Position to Gene	ave1	ave2	wilcoxon.w	wilcoxon.p	padj	dBeta
KIRC	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	5.83e-01	4.63e-01	3.05e+00	2.31e-03	3.25e-03	1.20e-01
HNSC	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	3.94e-01	6.08e-01	-3.94e+00	8.31e-05	2.22e-04	-2.14e-01
LUSC	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	3.16e-01	5.36e-01	-3.58e+00	3.38e-04	1.31e-03	-2.19e-01
CHOL	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	3.62e-01	6.64e-01	-2.58e+00	9.87e-03	2.15e-02	-3.02e-01

Differentially expressed CpG sites between female tumor and female normal patients.

Cancer Type	CpG Site	Position	CpG Island	Position to Gene	ave1	ave2	wilcoxon.w	wilcoxon.p	padj	dBeta
KIRC	cg26811602	chrX:46759327	CGI:chrX:46758578-46759534	promoter	3.92e-01	2.91e-01	2.51e+00	1.20e-02	1.93e-02	1.01e-01
LUAD	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	5.18e-01	6.45e-01	-3.55e+00	3.80e-04	1.74e-03	-1.27e-01
LIHC	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	5.99e-01	7.12e-01	-1.97e+00	4.89e-02	4.90e-02	-1.13e-01
KIRP	cg07343739	chrX:46758089	CGI:chrX:46758578-46759534	promoter,gene body	5.06e-01	6.11e-01	-2.39e+00	1.68e-02	2.38e-02	-1.05e-01

Top

Exon skipping events with PSI in TCGA for SLC9A7

∗Please access ExonSkipDB for exon skipping annotation.

Landscape of exon skipping events across multiple cancer types.

Differentially expressed exon skipping events between male tumor and female tumor patients.

Cancer Type

Exon Skipping

ave.female_T

ave.female_N

wilcoxon.w

wilcoxon.p

padj

dPSI

Differentially expressed exon skipping events between male tumor and male normal patients.

Cancer Type

Exon Skipping

ave.female_T

ave.female_N

wilcoxon.w

wilcoxon.p

padj

dPSI

Differentially expressed exon skipping events between female tumor and female normal patients.

Cancer Type

Exon Skipping

ave.female_T

ave.female_N

wilcoxon.w

wilcoxon.p

padj

dPSI

Top

RNA A-to-I editing events in TCGA for SLC9A7

∗Please access CAeditome for RNA editing annotation.

Landscape of RNA editing events across multiple cancer types.

Differentially expressed RNA editing events between male tumor and female tumor patients.

Cancer Type	Transcript	Editing	ave.male_T	ave.female_T	wilcoxon.w	wilcoxon.p	p_adj	dFre
LUAD	SLC9A7-201	chrX_46604525_-	1.81e-01	3.08e-01	-3.42e+00	6.20e-04	1.86e-02	-1.27e-01
LUAD	SLC9A7-201	chrX_46604606_-	5.11e-01	3.99e-01	2.38e+00	1.72e-02	3.58e-02	1.12e-01
LGG	SLC9A7-201	chrX_46603813_-	1.54e-01	1.18e-01	2.10e+00	3.58e-02	4.81e-02	3.58e-02
LGG	SLC9A7-201	chrX_46604606_-	3.90e-01	3.41e-01	2.02e+00	4.32e-02	4.90e-02	4.87e-02
LGG	SLC9A7-201	chrX_46604614_-	2.32e-01	1.79e-01	2.23e+00	2.58e-02	4.72e-02	5.34e-02
THCA	SLC9A7-201	chrX_46605069_-	3.02e-01	2.60e-01	2.28e+00	2.24e-02	4.91e-02	4.17e-02
THCA	SLC9A7-201	chrX_46605079_-	5.03e-01	4.31e-01	2.23e+00	2.60e-02	4.91e-02	7.16e-02
LUSC	SLC9A7-201	chrX_46604525_-	2.36e-01	3.46e-01	-2.00e+00	4.59e-02	4.91e-02	-1.10e-01
LUSC	SLC9A7-201	chrX_46604571_-	3.09e-01	3.72e-01	-2.30e+00	2.14e-02	4.91e-02	-6.33e-02
SKCM	SLC9A7-201	chrX_46604571_-	2.87e-01	2.16e-01	2.14e+00	3.27e-02	4.90e-02	7.08e-02
SKCM	SLC9A7-201	chrX_46604581_-	3.14e-01	2.01e-01	2.44e+00	1.47e-02	4.90e-02	1.13e-01
STAD	SLC9A7-201	chrX_46604495_-	2.66e-01	3.07e-01	-2.06e+00	3.93e-02	4.96e-02	-4.16e-02
STAD	SLC9A7-201	chrX_46604625_-	2.09e-01	2.95e-01	-2.11e+00	3.50e-02	4.96e-02	-8.54e-02
KIRP	SLC9A7-201	chrX_46605988_-	3.40e-01	2.27e-01	2.09e+00	3.68e-02	4.80e-02	1.14e-01
ESCA	SLC9A7-201	chrX_46605988_-	3.70e-01	3.00e-01	3.10e+00	1.91e-03	4.99e-02	7.04e-02
LAML	SLC9A7-201	chrX_46604571_-	2.72e-01	3.42e-01	-2.03e+00	4.28e-02	4.95e-02	-7.04e-02
DLBC	SLC9A7-201	chrX_46604518_-	6.25e-01	7.79e-01	-2.00e+00	4.54e-02	4.86e-02	-1.54e-01

Differentially expressed RNA editing events between male tumor and male normal patients.

Cancer Type	Transcript	Editing	ave.male_T	ave.female_T	wilcoxon.w	wilcoxon.p	p_adj	dFre
KIRC	SLC9A7-201	chrX_46604581_-	3.08e-01	1.86e-01	2.46e+00	1.40e-02	2.24e-02	1.22e-01
ESCA	SLC9A7-201	chrX_46605988_-	3.70e-01	2.61e-01	2.75e+00	6.00e-03	1.62e-02	1.09e-01

Differentially expressed RNA editing events between female tumor and female normal patients.

Cancer Type	Transcript	Editing	ave.male_T	ave.female_T	wilcoxon.w	wilcoxon.p	p_adj	dFre
BRCA	SLC9A7-201	chrX_46604495_-	2.85e-01	2.37e-01	3.23e+00	1.23e-03	2.34e-03	4.79e-02
BRCA	SLC9A7-201	chrX_46604518_-	8.27e-01	7.04e-01	6.06e+00	1.38e-09	8.30e-09	1.24e-01
BRCA	SLC9A7-201	chrX_46604561_-	2.12e-01	1.68e-01	2.50e+00	1.25e-02	1.68e-02	4.40e-02
BRCA	SLC9A7-201	chrX_46604571_-	3.57e-01	2.59e-01	5.21e+00	1.91e-07	8.17e-07	9.77e-02
BRCA	SLC9A7-201	chrX_46604589_-	2.30e-01	1.70e-01	2.78e+00	5.38e-03	8.30e-03	6.05e-02
BRCA	SLC9A7-201	chrX_46604606_-	4.74e-01	2.61e-01	8.33e+00	7.82e-17	1.29e-15	2.13e-01
BRCA	SLC9A7-201	chrX_46605069_-	3.43e-01	2.26e-01	4.20e+00	2.64e-05	7.48e-05	1.17e-01
BRCA	SLC9A7-201	chrX_46605079_-	5.41e-01	3.74e-01	7.03e+00	2.13e-12	1.93e-11	1.67e-01
BRCA	SLC9A7-201	chrX_46605128_-	2.81e-01	1.90e-01	2.77e+00	5.57e-03	8.55e-03	9.08e-02
THCA	SLC9A7-201	chrX_46604518_-	7.80e-01	6.94e-01	2.39e+00	1.68e-02	2.38e-02	8.60e-02
THCA	SLC9A7-201	chrX_46605079_-	4.31e-01	3.37e-01	2.73e+00	6.29e-03	1.25e-02	9.42e-02

Protein coding RNA editing(s).

Editing Position

Variant Type

Gene Symbol

Transcript ID

NTchange

AAchange

Top

Sex-biased TF-Gene network for SLC9A7

TFs related to SLC9A7.
∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98.
∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98.

Cancer Type	TF	Target Gene	Male Edge Score	Male Edge Threshold	Female Edge Score	Female Edge Threshold	Type
BLCA	MYNN	SLC9A7	3.12e+00	5.50e-03	4.11e+00	9.80e-01	Female-biased
BRCA	MYNN	SLC9A7	2.93e+00	5.44e-03	4.32e+00	9.81e-01	Female-biased
BRCA	POU3F3	SLC9A7	2.74e+00	2.45e-03	4.40e+00	9.86e-01	Female-biased
BRCA	SKOR1	SLC9A7	3.58e+00	1.08e-02	4.77e+00	9.83e-01	Female-biased
BRCA	SKOR2	SLC9A7	3.72e+00	1.36e-02	4.84e+00	9.81e-01	Female-biased
BRCA	ZNF418	SLC9A7	1.10e+00	3.45e-06	4.39e+00	9.88e-01	Female-biased
BRCA	ZNF79	SLC9A7	1.82e+00	1.83e-04	4.24e+00	9.84e-01	Female-biased
CHOL	ZNF418	SLC9A7	3.88e+00	9.81e-01	2.73e+00	4.60e-03	Male-biased
MESO	FOXG1	SLC9A7	2.37e+00	2.01e-03	4.10e+00	9.85e-01	Female-biased
MESO	FOXJ2	SLC9A7	2.52e+00	4.73e-03	4.01e+00	9.80e-01	Female-biased
MESO	FOXJ3	SLC9A7	2.65e+00	5.03e-03	4.12e+00	9.82e-01	Female-biased
MESO	MEF2A	SLC9A7	2.65e+00	5.51e-03	4.09e+00	9.81e-01	Female-biased
MESO	MYNN	SLC9A7	3.17e+00	8.35e-03	4.50e+00	9.84e-01	Female-biased
MESO	POU2F2	SLC9A7	2.82e+00	6.68e-03	4.21e+00	9.82e-01	Female-biased
MESO	POU3F3	SLC9A7	2.78e+00	3.25e-03	4.38e+00	9.88e-01	Female-biased
MESO	ZNF418	SLC9A7	2.66e+00	2.79e-04	4.89e+00	9.96e-01	Female-biased
MESO	ZNF570	SLC9A7	2.75e+00	5.79e-03	4.17e+00	9.82e-01	Female-biased
MESO	ZNF79	SLC9A7	2.57e+00	6.95e-04	4.58e+00	9.93e-01	Female-biased
SKCM	POU3F3	SLC9A7	4.59e+00	9.80e-01	3.50e+00	8.87e-03	Male-biased
SKCM	ZNF418	SLC9A7	4.35e+00	9.84e-01	2.64e+00	1.25e-03	Male-biased
SKCM	ZNF79	SLC9A7	4.37e+00	9.81e-01	3.04e+00	4.18e-03	Male-biased

SLC9A7 related gene.
∗Only the gene encode TF might with this result.
∗For more information please check Sex-biased TF-Coding gene network.

Top

Sex-biased RBP-ES network for SLC9A7

RBPs related to ES in SLC9A7.
∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98.
∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98.

Cancer Type

RBP

Target ES

Male Edge Score

Male Edge Threshold

Female Edge Score

Female Edge Threshold

Type

SLC9A7 related ES.
∗Only the gene encode RBP might with this result.
∗For more information please check Sex-biased RBP-ES network in cancer.

Top

Sex-biased CeRNA regulation of gene

Sex-biased CeRNA regulation of gene.

Gene ID

ceRNA(lncRNA-miRNA-mRNA)

Group

Cancer Type

Top

Sex-biased eQTL regulation of gene

Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).

eQTL

Description

Male-specific eQTL regulation.

SNP ID

SNP Info

Position to Gene

Effect Score

FDR

Cancer Type

Biased Type

Female-specific eQTL regulation.

SNP ID

SNP Info

Position to Gene

Effect Score

FDR

Cancer Type

Biased Type

Opposite sex-biased eQTL regulation.

SNP ID

SNP Info

Position to Gene

Male Effect

Male FDR

Female Effect

Female FDR

Sex-biased Gene in Cancer

Cancer Type

Top

Sex-biased eQTM regulation of gene

Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table).

eQTM	Description
	Gene ID: ENSG00000065923
	CpG Site: cg06128881
	Position to Gene: gene,promoter
	Male Effect: -0.434847837918663
	Female Effect: -
	Gene ID: ENSG00000065923
	CpG Site: cg06128881
	Position to Gene: gene,promoter
	Male Effect: -0.46724535952426
	Female Effect: -
	Gene ID: ENSG00000065923
	CpG Site: cg07343739
	Position to Gene: gene,promoter
	Male Effect: -0.111873739971796
	Female Effect: -

Male-specific eQTM regulation.

CpG Site	CpG Postion	Position to Gene	Effect Score	FDR	Cor.r	Cor.Pvalue	Cancer Type
cg06128881	chrX:46757407	gene,promoter	-0.434847837918663	4.39259905546824e-08	-0.4146692852441939	1.1164566305782762e-10	LUAD
cg06128881	chrX:46757407	gene,promoter	-0.46724535952426	3.57373774047307e-19	-0.5339563029292536	6.367278348239816e-23	SKCM
cg07343739	chrX:46758089	gene,promoter	-0.111873739971796	1.46007142082267e-18	-0.5290147532331495	1.8573934354533526e-22	SKCM

Female-specific eQTM regulation.

CpG Site

CpG Postion

Position to Gene

Effect Score

FDR

Cor.r

Cor.Pvalue

Cancer Type

Opposite sex-biased eQTM regulation.

CpG Site

CpG Postion

CpG Island

Position to Gene

Male Effect

Male FDR

Female Effect

Female FDR

Male Cor

Male P-value

Female Cor

Female P-value

Sex-biased Coding Gene

Cancer Type

Top

Sex-biased sQTL regulation of gene

Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).

sQTL

Description

Male-specific sQTL regulation.

ES ID

Skipped Exon

ORF Anno

SNP ID

SNP Info

SNP Position to ES

Effect Score

FDR

Cancer Type

Biased Type

Female-specific sQTL regulation.

ES ID

Skipped Exon

ORF Anno

SNP ID

SNP Info

SNP Position to ES

Effect Score

FDR

Cancer Type

Biased Type

Opposite sex-biased sQTL regulation.

ES ID

Skipped Exon

ORF Anno

SNP ID

SNP Info

SNP Position to ES

Male Effect

Male FDR

Female Effect

Female FDR

Cancer Type

Top

Sex-biased sQTM regulation of gene

Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).

sQTM

Description

Male-specific sQTM regulation.

EX ID

Skipped Exon

CPG Site

CPG Position

Position to EX Events

Effect Score

FDR

Cor.r

Cor.Pvalue

ORF_anno

Cancer Type

Female-specific sQTM regulation.

EX ID

Skipped Exon

CPG Site

CPG Position

Position to EX Events

Effect Score

FDR

Cor.r

Cor.Pvalue

ORF_anno

Cancer Type

Opposite sex-biased sQTM regulation.

EX ID

EX Info

Skipped Exon

CPG Site

CPG Position

CPG Island

Position to EX Events

Male Effect

Male FDR

Female Effect

Female FDR

Male Correlation

Male P-value

Female Correlation

Female P-value

ORF_anno

Cancer Type

Top

Related disease information of SLC9A7

Diseases associated with this gene (DisGeNET).

Gene ID

Gene Symbol

Disease ID

Disease Name

Number of PMID

Source

	Gene summary
	Gene structure and Gene expression level
	Sex-biased somatic mutation
	DNA methylation with beta values in gene
	Exon skipping events with PSI in TCGA
	RNA A-to-I editing events in TCGA
	Sex-biased TF-Gene network of gene
	Sex-biased RBP-ES network of gene
	Sex-biased CeRNA regulation of gene
	Sex-biased eQTL regulation of gene
	Sex-biased eQTM regulation of gene
	Sex-biased sQTL regulation of gene
	Sex-biased sQTM regulation of gene
	Related disease information of gene